Nashville Based DaySpring Pharma Announces Two New Board Members
November 14 2007 - 8:00AM
PR Newswire (US)
NASHVILLE, Tenn., Nov. 14 /PRNewswire/ -- DaySpring Pharma today
announced the addition John Thievon and Joe Williams to its Board
of Directors. Each brings specific expertise to the fulfillment of
DaySpring's business objectives. Mr. Kevin Esval, Chairman of
DaySpring, stated, "John Thievon brings a robust professional
background to the Board at a time when DaySpring's product
portfolio is poised for significant growth in both prescription and
OTC markets. His experience and tenure at Adams (NASDAQ:ARXT)
offers DaySpring direct applications into immolating Adam's
successful business plan." Mr. Thievon commented, "I am delighted
to join DaySpring's Board. With its unique operating platform,
current portfolio and pipeline, I hope to add to management's
already considerable expertise." Mr. Thievon serves as Executive
Vice President of Sales & Corporate Accounts. Previously, he
has led Business Development, Commercial Operations and Marketing
at Adams. Prior to Adams, Mr. Thievon held various positions with
IMS Health Inc, and Ortho Pharmaceuticals. He holds a Bachelor of
Business Administration degree from Pace University. Mr. Esval said
of Mr. Williams, "Joe Williams' addition to the Board brings a
wealth of experience in building organizations and capital raises
in the health care marketplace. His background provides a
tremendous advantage to DaySpring as it continues its aggressive
growth plans. Mr. Williams commented, "I'm looking forward to
participating on DaySpring's Board. The Company's passion for
growth is similar to those that I co-founded or was an early
investor". Mr. Williams was a co-founder, Chairman and CEO of
Coventry Corporation, a large managed care organization as well as
an early investor in other successful healthcare startup, including
Nashville based Cumberland Pharmaceuticals. The recipient of a
Bachelor of Science degree from Auburn University, he is also
active with Angel Flight, a voluntary pilot organization and very
involved in church and community activities. About DaySpring Pharma
DaySpring Pharma is a specialty pharmaceutical company focused on
acquiring, developing and commercializing prescription and
non-prescription products for specialty markets in Women's Health,
Pediatrics and Dermatology. For general information, please visit
the company's website: http://www.dayspringpharma.com/ DATASOURCE:
DaySpring Pharma CONTACT: Wade Smith of DaySpring Pharma,
+1-770-639-3276, Web site: http://www.dayspringpharma.com/
Copyright
Adams Respiratory Therapeutics (NASDAQ:ARXT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Adams Respiratory Therapeutics (NASDAQ:ARXT)
Historical Stock Chart
From Oct 2023 to Oct 2024